IL-6 can be overexpressed by COVID-19 patients, and higher levels of IL-6 have been shown to be associated with COVID-19 severity and worse prognosis (Costela-Ruiz et al., 2020; Del Valle et al., 2020). This evidence concerns the gene IL6 and COVID-19.